These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12356489)

  • 1. Direct thrombin inhibitors.
    Weitz JI; Crowther M
    Thromb Res; 2002 May; 106(3):V275-84. PubMed ID: 12356489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
    Bates SM; Weitz JI
    Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies.
    Leone G; Rossi E; Leone AM; De Stefano V
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):311-26. PubMed ID: 15320782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of thrombin inhibitors.
    Bates SM; Weitz JI
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():27F-32. PubMed ID: 11156731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current developments in antithrombotic therapy: the role of antithrombin agents.
    Breddin HK
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():1-8. PubMed ID: 12811005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New targets for antithrombotic drugs.
    Thiagarajan P
    Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy.
    Brill-Edwards P; Van Ryn-McKenna J; Cai L; Ofosu FA; Buchanan MR
    Thromb Haemost; 1992 Oct; 68(4):424-7. PubMed ID: 1448774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
    Raaz U; Kaeberich A; Maegdefessel L; Buerke M; Busshardt M; Schubert S; Russ M; Plehn A; Ebelt H; Werdan K; Schlitt A
    Thromb Haemost; 2010 Apr; 103(4):808-14. PubMed ID: 20174756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct thrombin inhibitors for anticoagulation.
    Nutescu EA; Wittkowsky AK
    Ann Pharmacother; 2004 Jan; 38(1):99-109. PubMed ID: 14742803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to thrombin inhibition.
    Weitz JI
    Thromb Res; 2003 Jul; 109 Suppl 1():S17-22. PubMed ID: 12818630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anticoagulant agents: direct thrombin inhibitors.
    Nutescu EA; Shapiro NL; Chevalier A
    Cardiol Clin; 2008 May; 26(2):169-87, v-vi. PubMed ID: 18406993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs. A review of small-molecule thrombin inhibitors.
    Hauptmann J
    Eur J Clin Pharmacol; 2002 Jan; 57(11):751-8. PubMed ID: 11868795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antithrombotic drugs in development.
    Verstraete M; Zoldhelyi P
    Drugs; 1995 Jun; 49(6):856-84. PubMed ID: 7641602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical use of a new class of anticoagulant drugs: the direct thrombin inhibitors].
    Puccio D; Montalto S; Valerio MC; Ventimiglia A; Caronia A; Novo S
    G Ital Cardiol (Rome); 2006 Nov; 7(11):739-46. PubMed ID: 17216915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current anticoagulant therapy--unmet clinical needs.
    Hirsh J
    Thromb Res; 2003 Jul; 109 Suppl 1():S1-8. PubMed ID: 12818628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct thrombin inhibitors: pharmacology and clinical relevance.
    Kam PC; Kaur N; Thong CL
    Anaesthesia; 2005 Jun; 60(6):565-74. PubMed ID: 15918828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.